Literature DB >> 23590359

A prototype tobacco-associated oral squamous cell carcinoma classifier using RNA from brush cytology.

Antonia Kolokythas1, Mitchell J Bosman, Kristen B Pytynia, Suchismita Panda, Herve Y Sroussi, Yang Dai, Joel L Schwartz, Guy R Adami.   

Abstract

BACKGROUND: Oral cancer in the form of squamous cell carcinoma (OSCC) is typically detected in advanced stages when treatment is complex and may not be curative. The need for surgical biopsy may contribute to delays in diagnosis and impede early detection. Multiple studies of RNA from surgically obtained tumor samples have revealed many genes differentially expressed with this disease. We sought to determine whether the identified mRNAs could be used as markers by a non-invasive detection system for OSCC using RNA from brush cytology.
METHODS: Levels of mRNAs from 21 genes known to be differentially expressed in head and neck squamous cell carcinoma surgical samples, compared with controls, were shown to be quantifiable in oral brush cytology samples. These mRNAs were quantified in a training set of 14 tumor and 20 non-malignant brush cytology samples from tobacco/betel nut users. With the measurement of two additional mRNAs and analysis using support vector machines algorithm for class prediction of these cancers was produced.
RESULTS: This OSCC classifier based on the levels of 5 mRNAs in RNA from brush cytology initially showed 0.93 sensitivity and 0.91 specificity in differentiating OSCC from benign oral mucosal lesions based on leave-one-out cross-validation. When used on a test set of 19 samples from 6 OSCCs and 13 non-malignant oral lesions, we found misclassification of only one OSCC and one benign lesion.
CONCLUSIONS: This shows the promise of using RNA from brush cytology for early OSCC detection and the potential for clinical usage of this non-invasive classifier.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  RNA; brush cytology; gene expression; oral squamous cell carcinoma; tobacco

Mesh:

Substances:

Year:  2013        PMID: 23590359      PMCID: PMC3740027          DOI: 10.1111/jop.12068

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  42 in total

1.  Selection and validation of differentially expressed genes in head and neck cancer.

Authors:  M A Kuriakose; W T Chen; Z M He; A G Sikora; P Zhang; Z Y Zhang; W L Qiu; D F Hsu; C McMunn-Coffran; S M Brown; E M Elango; M D Delacure; F A Chen
Journal:  Cell Mol Life Sci       Date:  2004-06       Impact factor: 9.261

Review 2.  Early detection of premalignant lesions and oral cancer.

Authors:  Toby O Steele; Arlen Meyers
Journal:  Otolaryngol Clin North Am       Date:  2011-02       Impact factor: 3.346

3.  Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. U.S. Collaborative OralCDx Study Group.

Authors:  J J Sciubba
Journal:  J Am Dent Assoc       Date:  1999-10       Impact factor: 3.634

Review 4.  Exciting new advances in oral cancer diagnosis: avenues to early detection.

Authors:  Ravi Mehrotra; Dwijendra K Gupta
Journal:  Head Neck Oncol       Date:  2011-07-28

5.  Interpretation of genomic data: questions and answers.

Authors:  Richard Simon
Journal:  Semin Hematol       Date:  2008-07       Impact factor: 3.851

Review 6.  Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of the literature.

Authors:  Lauren L Patton; Joel B Epstein; A Ross Kerr
Journal:  J Am Dent Assoc       Date:  2008-07       Impact factor: 3.634

7.  Examination of oral cancer biomarkers by tissue microarray analysis.

Authors:  Peter Choi; C Diana Jordan; Eduardo Mendez; John Houck; Bevan Yueh; D Gregory Farwell; Neal Futran; Chu Chen
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2008-05

8.  Genomewide gene expression profiles of HPV-positive and HPV-negative oropharyngeal cancer: potential implications for treatment choices.

Authors:  Pawadee Lohavanichbutr; John Houck; Wenhong Fan; Bevan Yueh; Eduardo Mendez; Neal Futran; David R Doody; Melissa P Upton; D Gregory Farwell; Stephen M Schwartz; Lue Ping Zhao; Chu Chen
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2009-02

9.  RNA from brush oral cytology to measure squamous cell carcinoma gene expression.

Authors:  Joel L Schwartz; Suchismita Panda; Craig Beam; Laura E Bach; Guy R Adami
Journal:  J Oral Pathol Med       Date:  2008-02       Impact factor: 4.253

10.  Smoking-induced gene expression changes in the bronchial airway are reflected in nasal and buccal epithelium.

Authors:  Sriram Sridhar; Frank Schembri; Julie Zeskind; Vishal Shah; Adam M Gustafson; Katrina Steiling; Gang Liu; Yves-Martine Dumas; Xiaohui Zhang; Jerome S Brody; Marc E Lenburg; Avrum Spira
Journal:  BMC Genomics       Date:  2008-05-30       Impact factor: 3.969

View more
  4 in total

1.  Gene expression based evidence of innate immune response activation in the epithelium with oral lichen planus.

Authors:  Guy R Adami; Alexander C F Yeung; Grant Stucki; Antonia Kolokythas; Herve Y Sroussi; Robert J Cabay; Igor Kuzin; Joel L Schwartz
Journal:  Arch Oral Biol       Date:  2014-01-04       Impact factor: 2.633

2.  microRNA-21 and microRNA-375 from oral cytology as biomarkers for oral tongue cancer detection.

Authors:  Qianting He; Zujian Chen; Robert J Cabay; Leitao Zhang; Xianghong Luan; Dan Chen; Tianwei Yu; Anxun Wang; Xiaofeng Zhou
Journal:  Oral Oncol       Date:  2016-03-31       Impact factor: 5.337

3.  microRNA from brush biopsy to characterize oral squamous cell carcinoma epithelium.

Authors:  Yalu Zhou; Antonia Kolokythas; Joel L Schwartz; Joel B Epstein; Guy R Adami
Journal:  Cancer Med       Date:  2016-12-18       Impact factor: 4.452

4.  Heat shock factor 1 in cancer-associated fibroblasts is a potential prognostic factor and drives progression of oral squamous cell carcinoma.

Authors:  Qiong Wang; Yu-Chao Zhang; Li-Fang Zhu; Lu Pan; Miao Yu; Wei-Li Shen; Bang Li; Wei Zhang; Lai-Kui Liu
Journal:  Cancer Sci       Date:  2019-04-11       Impact factor: 6.716

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.